Log in

Relevant bibliographies by topics / Proteasome System / Books

Books on the topic 'Proteasome System'

To see the other types of publications on this topic, follow the link: Proteasome System.

Author: Grafiati

Published: 23 September 2022

Last updated: 28 September 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 29 books for your research on the topic 'Proteasome System.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Mayor, Thibault, and Gary Kleiger, eds. The Ubiquitin Proteasome System. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8706-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

name, No. The ubiquitin-proteasome proteolytic system: From classical biochemistry to human diseases. Singapore: World Scientific, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rechsteiner, Martin, Aaron J. Ciechanover, and R. John Mayer. Ubiquitin-Proteasome System. Wiley & Sons, Incorporated, John, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rechsteiner, Martin, Aaron J. Ciechanover, and R. John Mayer. Ubiquitin-Proteasome System. Wiley & Sons, Limited, John, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ciechanover, Aaron J., and Maria G. Masucci. The Ubiquitin-Proteasome Proteolytic System. WORLD SCIENTIFIC, 2002. http://dx.doi.org/10.1142/5051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rechsteiner, Martin, Aaron J. Ciechanover, and R. John Mayer. Ubiquitin-Proteasome System and Disease. Wiley & Sons, Incorporated, John, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

(Editor), Leonidas Stefanis, and J. N. Keller (Editor), eds. The Proteasome in Neurodegeneration. Springer, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

The Ubiquitin Proteasome System: Methods and Protocols. Humana, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Rechsteiner, Martin, Aaron J. Ciechanover, and R. John Mayer. Cell Biology of the Ubiquitin-Proteasome System. Wiley & Sons, Incorporated, John, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Mayer, J., and R. Layfield. The Ubiquitin-proteasome System (Essays in Biochemistry). Portland Pr, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

(Editor), R. John Mayer, Aaron J. Ciechanover (Editor), and Martin Rechsteiner (Editor), eds. Protein Degradation: The Ubiquitin-Proteasome System (Protein Degradation). Wiley-VCH, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Gomes, Aldrin V. Ubiquitin Proteasome System: A Review and Directions for Research. Nova Science Publishers, Incorporated, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Rechsteiner, Martin, Aaron J. Ciechanover, and R. John Mayer. Cell Biology of the Ubiquitin-Proteasome System Vol. 3. Wiley & Sons, Limited, John, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

(Editor), Mario Di Napoli, and Cezary Wojcik (Editor), eds. The Ubiquitin Proteasome System in the Central Nervous System: From Physiology to Pathology. Nova Science Pub Inc, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

(Editor), R. John Mayer, Aaron J. Ciechanover (Editor), and Martin Rechsteiner (Editor), eds. Protein Degradation: Cell Biology of the Ubiquitin-Proteasome System (Protein Degradation). Wiley-VCH, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Summers, Matthew, ed. Ubiquitin Proteasome System - Current Insights into Mechanism Cellular Regulation and Disease. IntechOpen, 2019. http://dx.doi.org/10.5772/intechopen.78430.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

(Editor), Aaron J. Ciechanover, and Maria G. Masucci (Editor), eds. The Ubiquitin-Proteasome Proteolytic System: From Classical Biochemistry to Human Diseases. World Scientific Publishing, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

J, Ciechanover Aaron, and Masucci Maria G, eds. The ubiquitin-proteasome proteolytic system: From classical biochemistry to human diseases. Singapore: World Scientific, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Di, Napoli Mario, and Wójcik Cezary 1968-, eds. The ubiquitin proteasome system in the central nervous system: From physiology to pathology : 2008 update. Hauppauge, NY: Nova Science, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

(Editor), R. John Mayer, Aaron J. Ciechanover (Editor), and Martin Rechsteiner (Editor), eds. Protein Degradation: Vol. 4: The Ubiquitin-Proteasome System and Disease (Protein Degradation). Wiley-VCH, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Renton, Alan E., and Alison M. Goate. Genetics of Dementia. Edited by Dennis S. Charney, Eric J. Nestler, Pamela Sklar, and Joseph D. Buxbaum. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190681425.003.0051.

Full text

Abstract:

The genetic architecture of dementia is polygenic and complex, with risk alleles spanning frequency–effect size space. Despite significant progress, most genes influencing these disorders await discovery. Known risk loci implicate perturbed pathways that coalesce around recurring mechanistic themes, notably the autophagosome-lysosome system, the cytoskeleton, endocytosis, innate immunity, lipid metabolism, mitochondria, and the ubiquitin-proteasome system. Phenotypic and pathophysiological pleiotropy suggests some conditions form continuous clinicopathogenetic disease spectra blurring classical diagnoses. Future large-scale genome sequencing of global populations will significantly elucidate etiopathogenesis and is likely to reframe nosology. Furthermore integrative prospective cohort studies have the potential to revolutionize our understanding of dementia.

APA, Harvard, Vancouver, ISO, and other styles

22

Grune, Tilman. Proteasomal System in Aging and Disease. Elsevier Science & Technology Books, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

The Proteasomal System in Aging and Disease. Elsevier, 2012. http://dx.doi.org/10.1016/c2010-0-66760-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Nakamura, Tomohiro, and Stuart A. Lipton. Neurodegenerative Diseases as Protein Misfolding Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0002.

Full text

Abstract:

Neurodegenerative diseases (NDDs) often represent disorders of protein folding. Rather than large aggregates, recent evidence suggests that soluble oligomers of misfolded proteins are the most neurotoxic species. Emerging evidence points to small, soluble oligomers of misfolded proteins as the cause of synaptic dysfunction and loss, the major pathological correlate to disease progression in many NDDs including Alzheimer’s disease. The protein quality control machinery of the cell, which includes molecular chaperones as found in the endoplasmic reticulum (ER), the ubiquitin-proteasome system (UPS), and various forms of autophagy, can counterbalance the accumulation of misfolded proteins to some extent. Their ability to eliminate the neurotoxic effects of misfolded proteins, however, declines with age. A plausible explanation for the age-dependent deterioration of the quality control machinery involves compromise of these systems by excessive generation of reactive oxygen species (ROS), such as superoxide anion (O2-), and reactive nitrogen species (RNS), such as nitric oxide (NO). The resulting redox stress contributes to the accumulation of misfolded proteins. Here, we focus on aberrantly increased generation of NO-related species since this process appears to accelerate the manifestation of key neuropathological features, including protein misfolding. We review the chemical mechanisms of posttranslational modification by RNS such as protein S-nitrosylation of critical cysteine thiol groups and nitration of tyrosine residues, showing how they contribute to the pathogenesis of NDDs.

APA, Harvard, Vancouver, ISO, and other styles

25

Purintrapiban, Juntipa. Coordination of protease systems on muscle protein degradation and identification of calpain substrates using the yeast two-hybrid system. 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hodgkiss, Andrew. Psychiatric consequences of cancer treatments: ‘small molecule’ molecularly targeted agents. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198759911.003.0008.

Full text

Abstract:

The psychiatric consequences of a range of small-molecule, molecularly targeted systemic treatments for cancer are reviewed. Psychopathology may arise from the endocrine complications of VEGFR/multiple TK inhibitors. The mechanisms by which PI3K/AKT inhibition and proteasome inhibition can provoke anxiety and depressive phenomena in animals and humans are discussed. PARP-1 inhibition impairs memory acquisition in animal models and is neuroprotective. PARP-2 inhibitors display anti-neuroinflammatory properties in mice. The cognitive enhancing, mood stabilizing, and neuroprotective effects of HDAC inhibitors are considered.

APA, Harvard, Vancouver, ISO, and other styles

27

Kanno, Hiroshi, and Joachim P. Steinbach. Familial tumour syndromes: von Hippel–Lindau disease. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199651870.003.0016.

Full text

Abstract:

Von Hippel–Lindau (VHL) disease, an autosomal dominant familial tumour syndrome, is often associated with haemangioblastoma of the central nervous system. In the presence of oxygen, VHL protein serves to prevent the accumulation of hypoxia-inducible factor (HIF) protein by targeting it to the proteasomal pathway, while biallelic inactivation of the VHL gene blocks degradation of HIF and leads to constitutive activation of the HIF pathway although oxygen is present. HIF-target genes are involved in angiogenesis, proliferation, and metabolism enabling tumour growth. Haemangioblastoma is a highly vascularized, begin tumour commonly associated with a cyst, but it is linked with neurological morbidity and mortality based on its location and multiplicity. Haemangioblastoma in VHL is diagnosed according to symptoms and signs, past and family histories, laboratory data, neuroradiological findings, pathological findings, and genetic testing. Surgical treatment is usually the most recommended therapy for haemangioblastomas, and using well-defined microsurgical techniques, the majority can be resected safely.

APA, Harvard, Vancouver, ISO, and other styles

28

Berry, Martin, and Ann Logan. CNS Injuries: Cellular Responses and Pharmacological Strategies (Pharmacology & Toxicology (Crc Pr)). CRC, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

M, Berry, and Logan Ann, eds. CNS injuries: Cellular responses and pharmacological strategies. Boca Raton: CRC Press, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!